Hepatitis
Conference Coverage
ED-based HCV screening found feasible, linkage low
BOSTON – Among patients with homes, linkage to care was 59%, compared with 20% for patients who were homeless.
Conference Coverage
Hepatitis B debrief: Key themes that emerged at AASLD
BOSTON – Hot topics included HBV natural history, novel therapies, and prevention.
Conference Coverage
HVPG predicts clinical benefit after sustained virologic response
BOSTON – This provides, for the first time, firm evidence that HVPG can be taken as a surrogate endpoint for studies...
Conference Coverage
Short-course DAA therapy may prevent hepatitis transmission in transplant patients
BOSTON – While curing infection post transplant works, prevention would be preferable, investigators say.
From the Journals
Level of hepatitis B core–related antigen is risk factor for hepatocellular carcinoma
Compared with patients whose HBcrAg level was less than 10 KU/mL, a level of 10-99 KU/mL was associated with a nearly threefold increase in risk...
Conference Coverage
HDV combo therapy reduces viral loads
BOSTON – Interim results of the open-label LIFT trial show positive results after 6 months of therapy.
From the Journals
Hepatitis C vaccine alters viral trajectory, but fails in chronic infection protection
BOSTON – First-ever randomized study does suggest changes in peak HCV RNA and an HCV RNA change after infection.
From the Journals
HCV testing/awareness successful as part of HIV integrated care
From the Journals
Rare mixed HCV genotypes found in men who have sex with men
From the Journals
HCV+ kidney transplants: Similar outcomes to HCV- regardless of recipient serostatus
From the Journals
Direct-acting antiviral therapy boosts survival for infected HCC patients
Adults with a history of hepatocellular carcinoma had a significantly reduced risk of death after treatment of HCV infections with DAAs.